Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve Audited Financial Statements (Standalone) of the Company for the fourth quarter and year ended as on March 31, 2024 and to discuss any other matter with the permission of the Chair.